Why Microbot Medical Inc.’s (MBOT) Stock Is Down 6.72%
As of Tuesday, August 11, Microbot Medical Inc.’s MBOT share price has dipped by 6.72%, which has investors questioning if this is right time to buy.Cynthia McLaughlin
| SECTOR | INDUSTRY |
| Health Care | Health Care Equipment & Supplies |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Cynthia McLaughlin
Jenna Brashear
Cynthia McLaughlin
Cynthia McLaughlin
Michael Rose
| Share Statistics | MBOT | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $98.7 | $405.9 | 21% |
|
| Shares Out (Mil) | 67.2 | 41.6 | 54% |
|
| Institutional Ownership | na | 83.1% | na |
|
| Float (Mil) | 67.2 | 35.6 | 54% |
|
| Beta | 1.05 | 0.88 | 63% |
|
| Avg Daily Volume (000s) | 594 | 337 | 62% |
|
| Price Change (52-week) |
(61.4%) | 65.0% | 11% |
|
| Growth | MBOT | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 11.8% | na |
|
| Net Income (5yr) | (7.3%) | (5.9%) | 31% |
|
| EPS (5yr) | 25.9% | 10.2% | 76 |
|
| Dividends (5yr) | na | 0.0% | 0% |
|
| Cash Flow (5yr) | 15.0% | (15.6%) | 73% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 3 | 3 | 3 | |
| Current EPS | ($0.083) | ($0.313) | ($0.343) | |
| Month Ago EPS | ($0.073) | ($0.280) | ($0.297) | |
| # Rev Up | 1 | 1 | 1 | |
| # Rev Down | 0 | 0 | 0 | |
| Three Months Ago EPS | ($0.080) | ($0.310) | ($0.280) | |
| Year/Year Chg | (1.2%) | 9.1% | (2.4%) | |
| Financials | MBOT | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $0 | $119 | 1% |
|
| Net Income (TTM) (Mil) | ($16) | ($9) | 25% |
|
| EPS (TTM) | ($0.262) | ($0.400) | 32% |
|
| Operating Cash Flow (TTM) (Mil) | ($18) | ($3) | 16% |
|
| Net Cash Flow (TTM) (Mil) | na | $1 | na |
|
| Long-Term Debt (Q1) (Mil) | $1 | $22 | 15% |
|
| Enterprise Value (Q1) (Mil) | $38 | $371 | 14% |
|
| Valuation | MBOT | Industry Median |
Percentile (All Stocks) |
|
| P/B | 1.43 | 3.04 | 37% |
|
| P/E | na | 27.4 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.6 | na |
|
| Ratios | MBOT | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | (185.3%) | 58.5% | 1% |
|
| Net Margin | na | (6.9%) | na |
|
| ROA | (30.7%) | (13.1%) | 17% |
|
| ROE | (32.9%) | (13.1%) | 19% |
|
| Liabilities to Assets | 6.0% | 46.1% | 3% |
|
| F-Score | 2 | 4 | 7% |
|
Microbot Medical Inc. did not pass any screens on 9/1/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors